EL7.AI
StocksMediumUpdated×3•Originally published 23 July 2026•Updated 23 July 2026•
1 min read

Thermo Fisher Raises 2026 Guidance as US Corporate Earnings Coverage Expands

Key Facts

1Thermo Fisher reported 10% revenue growth to $11.99 billion with adjusted EPS rising 13% to $6.03.
2Honeywell announced sales of $9.7 billion and a backlog of $38 billion prior to the Aerospace spin-off.
3Cleveland-Cliffs reported a GAAP net loss of $134 million despite revenues increasing to $5.2 billion.

Reflecting growing optimism in the healthcare and life sciences sector, Thermo Fisher Scientific has raised its full-year 2026 financial guidance. This upward revision follows a strong second-quarter 'double beat,' where the company reported adjusted EPS of $6.03 against the $5.72 expected, on revenues of $11.99 billion, citing a notable recovery in customer activity across its primary end markets.

Per market data, corporate performance continues to diverge across the industrial and scientific landscapes. Thermo Fisher (TMO) closed at $526.46 (as of July 22, 2026), buoyed by its improved outlook. Conversely, Honeywell (HON) stood at $229.86 (as of July 21, 2026) following its $9.7 billion sales report, while Cleveland-Cliffs (CLF) closed at $9.45 (as of July 22, 2026) as investors reacted to a reported net loss of $134 million despite revenue growth.

Traders should watch for continued momentum in TMO shares following the guidance hike, while monitoring support for CLF after it touched a day low of $9.25 on July 22, 2026. Market attention remains on the integration of Comcast and Snap-On results into sector indices. With the Philadelphia Fed Manufacturing Index reaching 41.4 points—well above forecasts—industrial sentiment may provide further catalysts for firms like Honeywell and Snap-On in upcoming sessions.